Towa Pharmaceutical Co., Ltd.
TWAPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $50 | $35 | $45 | $29 |
| Short-Term Investments | $0 | $18 | $0 | $0 |
| Receivables | $57 | $59 | $61 | $68 |
| Inventory | $119 | $113 | $108 | $109 |
| Other Curr. Assets | $31 | $28 | $32 | $31 |
| Total Curr. Assets | $256 | $253 | $247 | $238 |
| Property Plant & Equip (Net) | $171 | $169 | $168 | $166 |
| Goodwill | $26 | $27 | $28 | $29 |
| Intangibles | $17 | $17 | $18 | $18 |
| Long-Term Investments | $0 | $1 | $3 | $1 |
| Tax Assets | $0 | $0 | $6 | $0 |
| Other NC Assets | $10 | $8 | $0 | $7 |
| Total NC Assets | $225 | $222 | $224 | $221 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $481 | $475 | $471 | $459 |
| Liabilities | – | – | – | – |
| Payables | $16 | $18 | $27 | $19 |
| Short-Term Debt | $30 | $28 | $23 | $16 |
| Tax Payable | $4 | $0 | $5 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $40 | $42 | $17 | $43 |
| Total Curr. Liab. | $91 | $90 | $88 | $79 |
| LT Debt | $192 | $197 | $195 | $197 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $4 | $4 | $5 |
| Total NC Liab. | $209 | $213 | $211 | $211 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $15 | $13 | $13 | $11 |
| Total Liabilities | $301 | $303 | $299 | $290 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $5 | $5 | $5 | $5 |
| Retained Earnings | $157 | $151 | $151 | $146 |
| AOCI | $0 | $15 | $14 | $16 |
| Other Equity | $16 | $0 | $0 | $0 |
| Total Equity | $180 | $173 | $172 | $169 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $481 | $475 | $471 | $459 |
| Net Debt | $172 | $189 | $172 | $183 |